Zai Lab Limited ADR (ZLAB): Next-Year EPS Estimate 25.63%
As of 2026-05-07, Zai Lab Limited ADR (ZLAB) has a next-year EPS growth estimate of 25.63%.
On 2026-05-07, analyst consensus for ZLAB's next-year EPS growth shifted from 28.45% to 25.63% — a negative change of 2.82 percentage points. Current-year growth is projected at -19.99%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.63%
- EPS growth this year
- -19.99%
- EPS next quarter (est)
- -$0.58
- Last price
- $19.76
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 25.63% | -19.99% | -$0.58 | $19.76 |
| 2026-05-06 | 28.45% | -18.19% | -$0.53 | $21.01 |
| 2026-05-05 | 28.45% | -18.19% | -$0.53 | $20.98 |
| 2026-05-04 | 27.72% | -17.57% | -$0.50 | $21.22 |
| 2026-05-03 | 27.72% | -17.57% | -$0.50 | $21.54 |
| 2026-04-30 | 27.72% | -17.57% | -$0.50 | $21.64 |
| 2026-04-29 | 27.72% | -17.57% | -$0.50 | $20.75 |
| 2026-04-28 | 27.72% | -17.57% | -$0.50 | $22.14 |
| 2026-04-27 | 27.72% | -17.57% | -$0.50 | $21.88 |
| 2026-04-26 | 27.72% | -17.57% | -$0.50 | $22.77 |
| 2026-04-24 | 27.72% | -17.57% | -$0.50 | $22.77 |
| 2026-04-23 | 27.72% | -17.57% | -$0.50 | $21.88 |
| 2026-04-22 | 27.72% | -17.57% | -$0.50 | $22.87 |
| 2026-04-21 | 27.68% | -17.00% | -$0.48 | $24.44 |
| 2026-04-20 | 28.07% | -16.30% | -$0.48 | $25.25 |
| 2026-04-19 | 30.18% | -10.19% | -$0.48 | $24.19 |
| 2026-04-16 | 30.18% | -10.19% | -$0.48 | $23.50 |
| 2026-04-15 | 30.18% | -10.19% | -$0.48 | $23.25 |
| 2026-04-14 | 31.43% | -9.68% | -$0.48 | $21.96 |
| 2026-04-13 | 31.43% | -9.68% | -$0.48 | $21.34 |
| 2026-04-12 | 31.43% | -9.68% | -$0.48 | $20.68 |
| 2026-04-10 | 31.43% | -9.68% | -$0.48 | $20.74 |
| 2026-04-09 | 31.43% | -9.68% | -$0.48 | $20.74 |
| 2026-04-08 | 31.43% | N/A | -$0.48 | $21.39 |
| 2026-04-07 | 31.43% | N/A | -$0.48 | $21.00 |
| 2026-04-06 | 31.43% | N/A | -$0.48 | $21.00 |
| 2026-04-05 | 31.43% | N/A | -$0.48 | $20.41 |
| 2026-04-03 | 31.43% | N/A | -$0.48 | $21.00 |
| 2026-04-02 | 31.43% | N/A | -$0.48 | $21.00 |
| 2026-04-01 | 31.43% | N/A | -$0.48 | $21.00 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Zai Lab Limited ADR's next-year EPS growth estimate?▾
As of 2026-05-07, Zai Lab Limited ADR (ZLAB) has a next-year EPS growth estimate of 25.63%, based on analyst consensus.
When was the latest EPS estimate revision for ZLAB?▾
The most recent revision occurred on 2026-05-07, when analysts adjusted the next-year EPS growth estimate from 28.45% to 25.63%.
What sector and industry does Zai Lab Limited ADR belong to?▾
Zai Lab Limited ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ZLAB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Zai Lab Limited ADR (ZLAB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports